Lilly's Growth Will Come From Alliances, Not Merger, VP Lechleiter Says
Partnership deals - as opposed to a merger - offer Lilly its best opportunities for growth, Lilly Senior VP-Pharmaceutical Products John Lechleiter said.
You may also be interested in...
DuPont expects to begin marketing a Barr-developed oncology product in the first quarter of 2001 under an agreement reached by the two companies in their Coumadin dispute.
The combined Glaxo SmithKline U.S. sales force would be able to call on 250,000 physicians during the first week of a major product launch, the companies told a Jan. 17 London press briefing on their proposed merger.
Merck will refrain from entering into co-promotion agreements to take advantage of its sales force capacity, CEO Raymond Gilmartin told securities analysts Dec. 9 at the company's Whitehouse Station, N.J. headquarters.